IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bry, L.
Right arrow Articles by Brenner, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bry, L.
Right arrow Articles by Brenner, M. B.

 Previous Article  |  Next Article 

Infection and Immunity, January 2006, p. 673-681, Vol. 74, No. 1
0019-9567/06/$08.00+0     doi:10.1128/IAI.74.1.673-681.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

CD4+-T-Cell Effector Functions and Costimulatory Requirements Essential for Surviving Mucosal Infection with Citrobacter rodentium

Lynn Bry,1,2* Manfred Brigl,1 and Michael B. Brenner1

Lymphocyte Biology Section, Division of Rheumatology, Immunology and Allergy, Department of Medicine,1 Department of Pathology, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts 021152

Received 14 June 2005/ Returned for modification 21 September 2005/ Accepted 24 October 2005

Citrobacter rodentium causes an attaching and effacing infection of the mouse colon. Surprisingly, protective adaptive immunity against this mucosal pathogen requires a systemic T-cell-dependent antibody response. To define CD4+ T-cell effector functions promoting this systemic defense of infected epithelial surfaces, studies were undertaken in weaning-age mice lacking costimulatory molecules CD28 or CD40L or cytokines gamma interferon (IFN-{gamma}) or interleukin-4 (IL-4). Adoptive transfer of CD4+ T cells from wild-type, CD28–/–, CD40L–/–, or IFN-{gamma}–/– donors to CD4–/– recipients delineated functions of these CD4+ T-cell-expressed molecules on the outcome of infection. Wild-type and IL-4–/– mice successfully resolved infection, while 70% of IFN-{gamma}–/– mice survived. In contrast, all CD28–/– mice succumbed during acute infection. While fewer than half of CD40L–/– mice succumbed acutely, surviving mice failed to clear infection, resulting in progressive mucosal destruction, polymicrobial sepsis, and death 1 to 2 weeks later than in CD28–/– mice. Downstream of CD28-mediated effects, CD4+ T-cell-expressed CD40L proved essential for generating acute pathogen-specific immunoglobulin M (IgM) and early IgG, which reduced pathogen burdens. However, deficiency of CD4+ T-cell-expressed IFN-{gamma} did not adversely impact survival or development of protective antibody in adoptively transferred CD4–/– recipients, though it impacted Th1 antibody responses. These findings demonstrate that CD4+ T-cell-expressed CD40L promotes the rapid production of protective systemic antibody during acute infection, while deficiencies of IL-4 or of CD4+ T-cell-expressed IFN-{gamma} can be overcome. These findings have important implications for understanding the role of T-helper-cell responses during infections involving mucosal surfaces.


* Corresponding author. Mailing address: 4226-EBRC, Department of Pathology, Brigham & Women's Hospital, Harvard Medical School, Boston, MA 02115. Phone: (617) 732-7763. Fax: (617) 264-6898. E-mail: lbry{at}partners.org.

Editor: A. D. O'Brien


Infection and Immunity, January 2006, p. 673-681, Vol. 74, No. 1
0019-9567/06/$08.00+0     doi:10.1128/IAI.74.1.673-681.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2006 by the American Society for Microbiology. All rights reserved.